Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Sell Blue Apron Stock Now, Buy on Weakness Later

By Larry Ramer, InvestorPlace Contributor

Investors should sell Blue Apron stock now and buy the shares on weakness in May or June if they drop to $6.50-$7.50.

Surveys, Opening States, Oil Prices All Bode Well for United Airlines Stock

By Larry Ramer, InvestorPlace Contributor

Survey results, antibody tests, and bargain basement oil prices are among the factors that bode very well for UAL stock.

There Are Plenty of Hard Times Ahead for Qualcomm Stock

By Larry Ramer, InvestorPlace Contributor

Qualcomm stock has too many headwinds to maintain its current price. With the global economy slowing, it's not a great time to buy.

DAL Stock Is Set to Rebound After Re-Opening Measures Are Complete

By Larry Ramer, InvestorPlace Contributor

Fears of coronavirus are easing and the nation is starting to reopen. As a result, DAL stock should climb further going forward.

Moderna Faces Tough Threats in the Short and Long Term

By Larry Ramer, InvestorPlace Contributor

Moderna is facing meaningful short-term and longer-term threats. As a result, investors should sell MRNA stock at this point.

Load More